Sully and Mary talk to Cary Claiborne CEO of Adial Pharmaceuticals about their lead investigational new drug candidate, AD04, which is currently being investigated for the potential treatment of Alcohol Use Disorder (AUD).
February 7, 2023
Sully and Mary talk to Cary Claiborne CEO of Adial Pharmaceuticals about their lead investigational new drug candidate, AD04, which is currently being investigated for the potential treatment of Alcohol Use Disorder (AUD).
Other Interviews
